
Anti-VEGF Injections for Wet AMD
Why Anti-VEGF Injections Are the Standard Treatment
Wet AMD is a serious eye condition that can cause rapid vision loss if left untreated. Anti-VEGF injections have become the gold standard because they directly target the biological process driving the disease, giving most patients a meaningful chance to stabilize or even improve their vision.
Wet AMD occurs when abnormal blood vessels grow beneath the macula, which is the small central area of your retina responsible for sharp, detailed sight. These vessels are fragile and prone to leaking fluid and blood into the layers of the retina, causing swelling that damages the photoreceptor cells you rely on for reading, driving, and recognizing faces. Without treatment, scar tissue can form within weeks, making the vision loss permanent.
VEGF, or vascular endothelial growth factor, is a protein your body produces that signals abnormal blood vessels to grow and leak. Anti-VEGF drugs work by blocking this protein, which dries up existing fluid, stops further leaking, and prevents new abnormal vessels from forming. These medications stabilize vision in a large majority of patients and improve vision in a meaningful portion of those treated.
Several anti-VEGF medications are used to treat wet AMD. Each targets VEGF but differs in its molecular structure, how long its effect lasts, dosing intervals, and cost. Your retina specialist selects the right medication based on your specific disease characteristics, how you respond to treatment, your insurance coverage, and practical considerations such as how frequently you can come in for appointments.
- Aflibercept: blocks VEGF-A and placental growth factor
- Ranibizumab: an antibody fragment that blocks VEGF-A
- Faricimab: blocks both VEGF-A and angiopoietin-2, a dual-action approach that may allow longer intervals between injections
- Bevacizumab: used off-label, blocks VEGF-A at a significantly lower cost
All of these options have been shown to produce strong visual outcomes. Your specialist will discuss which medication makes the most sense for you.
What to Expect During the Procedure
Many patients feel anxious before their first injection, but the procedure is quick and well-tolerated. Understanding each step can help ease any apprehension and prepare you for a smooth experience.
Your retina specialist begins by numbing your eye with anesthetic drops and then cleans the surface of the eye with an antiseptic solution to minimize infection risk. A small device called a lid speculum is placed to gently hold your eye open so you do not need to concentrate on keeping it still. The entire preparation process takes only a few minutes, and you will be reclined comfortably in an exam chair throughout.
The injection itself takes only a fraction of a second. Your doctor uses a very fine needle to pass through the white part of the eye, called the sclera, and deliver the medication into the vitreous, which is the clear gel-filled space inside your eye behind the lens. Most patients report feeling pressure or a brief mild sting rather than sharp pain. The numbing drops do an effective job of keeping discomfort to a minimum.
Your doctor will check your eye pressure before you leave the office. It is normal to notice some redness on the white of the eye from the antiseptic preparation, as well as a gritty or foreign body sensation and mild light sensitivity for about 24 hours following the procedure. These effects resolve on their own without any special treatment.
- Do not rub your treated eye for the remainder of the day
- Arrange for someone to drive you home, as your vision may be temporarily blurry
- You can return to most normal activities the following day
- Contact your retina specialist right away if you experience sudden vision changes, worsening pain, or a significant increase in floaters
Treatment Schedule and Long-Term Expectations
Wet AMD is a chronic condition, which means anti-VEGF treatment is an ongoing commitment rather than a one-time fix. Understanding how the schedule works helps you and your care team stay on the same page and protect your vision over time.
Treatment begins with a loading phase, typically three to four monthly injections given consecutively. This initial series builds up a therapeutic level of the medication in your eye, bringing the abnormal blood vessel activity under control and clearing the accumulated fluid. Most patients experience their most noticeable improvement during this phase as swelling resolves and the retinal cells begin to recover.
Because anti-VEGF medications slow wet AMD rather than cure it, ongoing injections are necessary to keep the disease in check. After the loading phase, your retina specialist will gradually extend the time between injections based on how your eye responds. Some patients reach intervals of two to four months between treatments, while others require more frequent visits. It is important never to stop treatment without your doctor's guidance, as disease reactivation can cause new vision loss.
At each visit, your specialist will check your visual acuity and perform OCT imaging (optical coherence tomography), a painless scan that reveals whether fluid is present in your retinal layers. A dry retina on OCT means your current treatment interval is working well. If fluid reappears, your doctor may shorten the interval between injections or consider switching to a different medication. This approach, called treat-and-extend, aims to control the disease with the fewest injections necessary while protecting your vision.
Risks and Safety Considerations
Anti-VEGF injections have an excellent safety record when performed by an experienced retina specialist using proper sterile technique. Being informed about potential side effects and warning signs helps you respond quickly if anything unusual occurs.
The most frequently reported effects after an injection are temporary blurred vision, mild eye discomfort, redness on the white of the eye, and small floaters in your visual field. These typically resolve within a few days without any treatment. A brief, mild rise in eye pressure immediately after the injection is also common and generally returns to normal levels within an hour.
Serious complications are uncommon. Endophthalmitis, which is an infection inside the eye, and retinal detachment are the most significant risks but occur in fewer than one in a thousand injections. Your retina specialist reduces these risks through careful sterile technique, antiseptic preparation of the eye, and precise needle placement. Reassuringly, the risk of these complications does not increase with the number of injections you receive over time.
Certain symptoms after an injection are not normal and require immediate contact with your retina specialist. Do not wait to see if these symptoms improve on their own, as prompt treatment is critical to preserving your vision.
- Sudden or significant loss of vision
- Pain that is worsening rather than improving
- A large or sudden increase in floaters or flashes of light
- A dark shadow or curtain appearing across any part of your vision
Frequently Asked Questions
These are some of the questions our patients ask most often about anti-VEGF treatment. If something is not covered here, our team is always happy to explain in more detail at your appointment.
The numbing drops used before the procedure are effective at preventing sharp pain, and the injection itself is over in less than a second. Most patients find that the anxiety beforehand is more uncomfortable than the procedure itself. The gritty or foreign body sensation that some people notice afterward is normal and typically fades within a day. If discomfort after the injection feels severe or is getting worse rather than better, reach out to our office.
There is no fixed total, and the number varies from person to person. Wet AMD is a long-term condition, so injections are ongoing for many patients, sometimes for years. The good news is that many people need fewer injections per year over time as their treatment interval is extended. Your retina specialist will give you a clearer picture of your personal outlook based on how your eye responds to the loading phase and early treatment.
If OCT imaging shows that fluid is returning despite treatment, your specialist has several options. Switching to a different anti-VEGF drug, adjusting how frequently you receive injections, or in some cases combining treatment approaches are all possibilities. Losing response to one medication does not mean you have exhausted your options. Our retina specialists review your imaging and treatment history carefully to determine the best next step.
The most effective things you can do are keep every scheduled appointment, report any vision changes between visits promptly, and follow your specialist's recommended treatment plan. Skipping visits or delaying injections can allow the disease to become more active, which may actually require more injections to bring back under control. Newer medications with longer-lasting effects have also made extended intervals between injections possible for many patients compared to older treatment options.
Large clinical studies have shown that available anti-VEGF medications generally produce similar visual outcomes overall. The meaningful differences lie in how often injections are needed, the specific mechanisms each drug uses to block VEGF activity, and cost. Your specialist considers your individual disease pattern, insurance plan, and treatment history when recommending a medication. This is a decision made together, and you are always welcome to ask questions about why a particular drug is being recommended for you.
The chance of losing vision as a direct result of an anti-VEGF injection is very low. The far greater threat to your vision is wet AMD that goes untreated or under-treated, which causes progressive and often irreversible damage to your macula. When weighed against the risks of leaving wet AMD unmanaged, the benefits of treatment are clear. Our retina specialists take every precaution to make each procedure as safe as possible.
Protecting Your Vision With Expert Retina Care
Rhode Island Eye Institute is home to fellowship-trained retina specialists, including Dr. Gaurav Gupta and Dr. Pranjal Thakuria, who provide comprehensive wet AMD care backed by advanced diagnostic imaging and a personalized treat-and-extend approach. We have helped patients across Rhode Island and the surrounding region preserve their vision through expert anti-VEGF treatment and attentive long-term monitoring. If you have been diagnosed with wet AMD or are noticing changes in your central vision, we encourage you to schedule an appointment so we can evaluate your eyes and discuss a treatment plan designed around your needs.